Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions

Human Pathology

Volumn 41, Issue 4, 2010, Pages 503-512

  Miracco, Clelia ^a   Cevenini, Gabriele ^a   Franchi, Alessandro ^b   Luzi, Pietro ^a   Cosci, Elena ^a   Mourmouras, Vasileios ^a   Monciatti, Irene ^a   Mannucci, Susanna ^a   Biagioli, Maurizio ^a   Toscano, Marzia ^a   Moretti, Daniele ^a   Lio, Roberto ^a   Massi, Daniela ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Beclin 1 and LC3 autophagic genes; Immunohistochemistry; Melanocytic skin lesions; Real time reverse transcriptase PCR; Western blotting

Indexed keywords

BECLIN 1; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CUTANEOUS MELANOCYTIC LESION; DYSPLASTIC NEVUS; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH CURVE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LC3 GENE; MAJOR CLINICAL STUDY; MELANOCYTIC NEVUS; MITOSIS; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; TUMOR GROWTH; ULCER; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; NEVUS, PIGMENTED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77649335850     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.09.004     Document Type: Article

References (43)

1. Eskelinen E.L., and Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta 2009 (1793) 664-673
2. Yu L., Strandberg L., and Lenardo M.J. The selectivity of autophagy and its role in cell death and survival. Autophagy 4 (2008) 567-573
3. Chen N., and Karantza-Wadsworth V. Role and regulation of autophagy in cancer. Biochim Biophys Acta (2009) 10.1016/j.bbamcr.2008.12.013
4. Jin S., and White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 4 (2008) 563-566
5. Gozuacik D., and Kimchi A. Autophagy and cell death. Curr Topics Dev Biol 78 (2007) 217-245
6. Bialik S., and Kimchi A. Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development. Adv Exp Med Biol 615 (2008) 177-200
7. Cheong H., and Klionsky D.J. Biochemical methods to monitor autophagy-related processes in yeast. Methods Enzymol 451 (2008) 1-26
8. Kabeya Y., Mizushima N., Ueno T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. Embo J 19 (2000) 5720-5728
9. Klionsky D.J., Abeliovich H., Agostinis P., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 (2008) 151-175
10. Qu X., Yu J., Bhagat G., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112 (2003) 1809-1820
11. Lee J.W., Jeong E.G., Lee S.H., Yoo N.J., and Lee S.H. Somatic mutations of BECN1, an autophagy-related gene, in human cancers. APMIS 115 (2007) 750-756
12. Marino G., Salvador-Montoliu N., Fueyo A., et al. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282 (2007) 18573-18583
13. Ran K.M., Kim M.S., Oh J.E., et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol (2008) 10.1002/path.2509
14. Liang X.H., Jackson S., Seaman M., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402 (1999) 672-676
15. Yue Z., Jin V., Yang C., Levine A., and Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100 (2003) 15077-15082
16. Mathew R., Kongara S., Beaudoin B., et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21 (2007) 1367-1381
17. Miracco C., Cosci E., Oliveri G., et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumors. Int J Oncol 30 (2007) 429-436
18. Shen Y., Li D.D., Wang L.L., Deng R., and Zhu X.F. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 16 (2008) 1067-1068
19. Chen Y., Lu Y., Lu C., and Zhang L. Beclin 1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res 9 (2009)
20. Pirtoli L., Cevenini G., Tini P., et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 5 (2009) 7
21. Li B.X., Li C.Y., Peng R.Q., et al. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 5 (2009) 303-306
22. Shi Y.H., Ding Z.B., Zhou J., Qiu S.J., and Fan J. Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy 5 3 (2009) 380-382 Epub 2009 Apr 19
23. Ahn C.H., Jeong E.G., Lee J.W., et al. Expression of beclin 1, an autophagy-related protein, in gastric and colorectal cancers. Apmis 115 (2007) 1344-1349
24. Sato K., Tsuchihra K., Fujii S., et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 67 (2007) 9677-9684
25. Yoshioka A., Miyata H., Doki Y., et al. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancer. Int J Oncol 33 (2008) 461-468
26. Aoki H., Kondo Y., Aldape K., et al. Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 4 (2008) 467-475
27. Fujii S., Mitsunaga S., Yamazaki M., et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 99 (2008) 1813-1819
28. de Bruin E.C., and Medema J.P. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev 34 (2008) 737-749
29. Liang X.H., Yu J., Brown K., and Levine B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res 61 (2001) 3443-3449
30. Martinet W., De Meyer G.R., Andries L., Herman A.G., and Kockx M.M. Detection of autophagy in tissue by standard immunohistochemistry: possibilities and limitations. Autophagy 2 (2006) 55-57
31. Martinet W., De Meyer G.R., Andries L., Herman A.G., and Kockx M.M. In situ detection of starvation-induced autophagy. J Histochem Cytochem 54 (2006) 85-96
32. Degenhardt K., Mathew R., Beaudoin B., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006) 51-64
33. Satyamoorthy K., and Herlyn M. Cellular and molecular biology of human melanoma. Cancer Biol Ther 1 (2002) 14-17
34. Stahl J.M., Sharma A., Cheung M., et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64 (2004) 7002-7010
35. Sinnberg T., Lasithiotakis K., Niessner H., et al. Inhibition of PI3K-Akt-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. J Invest Dermatol 129 (2009) 1500-1515
36. Sharma A., Sharma A.K., Madhunapantula S.V., et al. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clin Cancer Res (2009) 10.1158/1078-0432 CCR-08-2214
37. Mathieu V., Le Mercier M., De Neve N., et al. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 127 (2007) 2399-2410
38. Trinh V.A. Current management of metastatic melanoma. AM Health Syst Pharm 65 (2008) S3-S8
39. Augustine C.K., Yoo J.S., Potti A., et al. Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 15 (2009) 502-510
40. Naumann S.C., Roos W.P., Jöst E., et al. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DBSs, and p53. Br J Cancer 100 (2009) 322-333
41. Zheng M., Bocangel D., Ramesh R., et al. Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of 06-methylguanine-DNA-methyltransferase in human melanoma cells. Mol Cancer Ther 7 (2008) 3842-3851
42. Liu B., Cheng Y., Zhang B., et al. Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS-p38-p53 pathway. Cancer Lett 275 (2009) 54-60
43. Ganesan A.K., Ho H., Bodemann B., et al. Genome-wide-siRNA-based functional genomics of pigmentation identifies novel genes and pathways that impact melanogenesis in human cells. PLoS Genet (2008) 10.1371/journal.pgen.1000298